Blood enzyme may signal psychosis risk in meth users
NCT ID NCT07434401
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study measured a specific enzyme in the blood of 93 people to see if it is linked to psychotic symptoms in methamphetamine users. Participants included people with methamphetamine use disorder, those with methamphetamine-induced psychosis, and healthy volunteers. The goal was to understand the biological factors behind these symptoms.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METHAMPHETAMINE INDUCED PSYCHOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Elazığ Mental Health and Diseases Hospital
Elâzığ, Elâzığ, 23200, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a psychedelic help break meth addiction in people with HIV?
- Weight-Loss drug may curb stimulant cravings, brain scans suggest
- Could an antidepressant help curb meth use in people treated for opioid addiction?
- Hormone therapy shows promise in preventing relapse in postpartum meth users
- Could ketamine therapy help people quit meth?
- Could a diabetes drug curb ice addiction? new trial aims to find out